Cancer remains one of India’s most pressing public health challenges, with rising incidence rates compounded by late-stage diagnosis, uneven access to screening facilities, and limited availability of India-specific research data. 

For large sections of the population, particularly those in underserved and rural communities, awareness about early symptoms is low, preventive screening is scarce, and timely referral to appropriate care is often delayed. 

These systemic gaps not only increase mortality rates but also place an immense emotional and financial burden on families. Addressing these interconnected challenges requires an approach that goes beyond treatment alone, combining early detection, prevention, research, and capacity building. 

In response to this need, Hyundai Motor India Foundation (HMIF), in collaboration with IIT Madras, launched Hyundai Hope for Cancer, a comprehensive initiative designed to strengthen India’s cancer care ecosystem through community outreach and cutting-edge genomic science.

Expanding Access to Early Detection at the Community Level

One of the most significant barriers to effective cancer care in India is delayed diagnosis. Many cancers, when detected early, are highly treatable, yet a lack of awareness and limited screening infrastructure often result in cases being identified at advanced stages. The Hyundai Hope for Cancer initiative directly addresses this issue by taking screening and awareness programs to communities that need them most.

Since its launch, the initiative has conducted 109 cancer awareness and screening camps across Tamil Nadu, collectively reaching 11,095 individuals. These camps were designed to provide accessible, on-ground screening for some of the most prevalent cancers in India, including oral, cervical, colon, breast, and prostate cancers. 

By focusing on these cancer types, the program aligns its efforts with national health priorities and disease burden patterns.

Beyond screening, these camps also played a crucial role in educating individuals and families about early warning signs, risk factors, and the importance of regular check-ups. Awareness sessions helped demystify cancer, reduce stigma, and encourage proactive health-seeking behavior. 

Importantly, individuals who tested positive during screenings were not left without follow-up support. A total of 448 individuals were identified as positive and referred to government hospitals for advanced diagnostics and treatment, ensuring integration with the public healthcare system and continuity of care.

Building a Strong Foundation for Cancer Genomics Research

While early detection is vital, long-term progress in cancer care also depends on a robust research infrastructure that reflects the genetic diversity of India’s population. Historically, much of global cancer genomics research has been based on Western populations, limiting its applicability to Indian patients. Recognizing this gap, Hyundai Hope for Cancer has invested in building India-specific research capabilities.

At the center of this effort is the Hyundai Centre for Cancer Genomics at IIT Madras. The centre houses India’s first community-based Cancer Tissue Biobank, a critical resource for advancing cancer research. 

Through this biobank, 1,104 cancer tissue samples have been collected, creating a valuable repository that reflects real-world patient diversity. Whole-genome sequencing has already been completed for 528 pediatric leukemia cases, marking a major step forward in understanding childhood cancers within the Indian context.

The ongoing genomic analysis aims to identify India-specific biomarker gene panels that can support earlier diagnosis, more accurate disease tracking, and improved treatment planning. These insights have the potential to reduce trial-and-error approaches in oncology and move towards more precise, personalized care tailored to Indian patients.

Complementing the biobank is the Bharat Cancer Genome Atlas (BCGA), launched as India’s first open-access cancer genome database and hosted by IIT Madras. 

By making genomic data accessible to researchers, clinicians, and institutions across the country, BCGA aims to accelerate collaboration, innovation, and discovery. This open-access model ensures that research benefits are shared widely, fostering a collective approach to tackling cancer at a national level.

Driving Prevention Through HPV Vaccination and Mobile Screening

Prevention forms a critical pillar of sustainable cancer care, particularly for cancers linked to known risk factors. Cervical cancer, which is closely associated with Human Papillomavirus (HPV), remains one of the leading causes of cancer-related deaths among women in India. Vaccination against HPV is a proven preventive measure, yet coverage remains limited in many regions.

As part of Hyundai Hope for Cancer, an HPV vaccination drive was conducted in collaboration with healthcare partners across districts such as Ariyalur, Virudhunagar, and Salem in Tamil Nadu. 

Through this effort, 525 girls were vaccinated against HPV, contributing to a long-term reduction in cervical cancer risk. This preventive intervention not only protects individual health but also supports broader public health goals by reducing future disease burden.

In addition to vaccination, the initiative has deployed a fully equipped Cancer Screening Vehicle to extend its reach. This mobile unit has already covered 17 districts in Tamil Nadu, enabling access to screening services in areas where fixed healthcare infrastructure may be limited. 

Mobile screening plays a vital role in bridging geographic and accessibility gaps, especially for populations that may otherwise forego preventive care due to distance, cost, or lack of awareness.

Impact Created

The Hyundai Hope for Cancer initiative has created a measurable and multidimensional impact within a relatively short period. More than 11,000 individuals have benefited directly from awareness and screening activities, leading to early identification and referral of hundreds of cancer cases. 

The establishment of a community-based Cancer Tissue Biobank and the sequencing of over 500 paediatric cancer genomes have strengthened India’s research capabilities and laid the foundation for more relevant, data-driven oncology solutions.

Through the launch of the Bharat Cancer Genome Atlas, the initiative has enabled open access to critical genomic data, supporting collaboration and accelerating research across institutions. Preventive interventions, including HPV vaccination and mobile screening services, have further expanded the scope of impact by addressing cancer risk before disease onset. 

Collectively, these efforts have contributed to improved awareness, early detection, research advancement, and preventive care, touching over 11,000 lives and strengthening the broader cancer care ecosystem.

Way Forward

Looking ahead, Hyundai Hope for Cancer is set to scale its efforts significantly over the next four years. Plans include conducting more than 225 cancer awareness and screening camps across Tamil Nadu, Haryana, and Maharashtra, to reach approximately 1.27 lakh individuals. The initiative also aims to vaccinate over 5,000 girls against HPV, reinforcing its commitment to preventive healthcare.

Expansion of the mobile cancer screening program to states such as Maharashtra and Haryana will further enhance access to early detection services. In parallel, the initiative plans to support free cancer treatment for underprivileged children in partnership with leading healthcare institutions, addressing financial barriers to care. 

Capacity building remains a key focus, with a technician training program planned to upskill more than 100 laboratory professionals in genomic sequencing and molecular oncology by FY 2026.

Through continued investment in community outreach, research infrastructure, prevention, and skill development, Hyundai Hope for Cancer aims to create a more equitable, inclusive, and future-ready cancer care ecosystem in India, one that prioritizes early action, leverages science, and delivers long-term impact at scale.